News

VIDEO: What's next for lung cancer detection and treatment?

Publish date: January 14, 2014
By
Doug Brunk

 

In an interview at the Joint Conference on the Molecular Origins of Lung Cancer, Dr. Roy Herbst, chief of medical oncology at the Yale Cancer Center in New Haven, Conn., offers his perspectives on new developments in lung cancer screening and treatment, and he discusses the promise that genetically targeted approaches and immunotherapy may offer.

Recommended Reading

FDA approves once-daily combination treatment inhaler for COPD
MDedge Internal Medicine
What Matters – Higher-dose varenicline
MDedge Internal Medicine
USPSTF gives final recommendation on lung cancer screening
MDedge Internal Medicine
Smoking rate among people with mental illness shows negligible decline
MDedge Internal Medicine
Smoking cessation maintained with varenicline plus CBT
MDedge Internal Medicine
Bupropion-varenicline combo gave harder kick to smoking habits
MDedge Internal Medicine
CPAP alternative? Implantable neurostimulator reduced apnea severity
MDedge Internal Medicine
Pediatricians, cancer groups ask regulators to help cut tobacco use
MDedge Internal Medicine
CV risk in former light smokers reduced sooner than in heavy smokers
MDedge Internal Medicine
Methotrexate less risky for lungs in RA than previously thought
MDedge Internal Medicine